Sangamo Therapeutics said the Food and Drug Administration has cleared its investigational new drug application for its ST-400 treatment for intractable pain due to idiopathic small fiber neuropathy.

A team of international researchers including those from the University of Adelaide have taken a well-known chemical reaction ...

A recent study from the Federal University of São Paulo (UNIFESP) has found that using infrared light along with regular ...

Are you searching for effective medications to treat 'Diabetic Neuropathy'? This comprehensive guide provides the latest information on medications-both generic and branded-that are essential for ...

A team of international researchers, including scientists from the University of Adelaide, has developed a new approach to pain relief using a well-known chemical reaction. This new method, which ...

Scientists have designed a groundbreaking painkiller that activates solely at chronic pain sites, offering targeted, ...

The company will present these findings and data from previous studies at the upcoming Pain Therapeutics Summit. The company is preparing to submit an Investigational New Drug (IND) application by ...

MIRA Pharmaceuticals, Inc. (NASDAQ:MIRA) stock is trading higher on Monday after the company released new preclinical ...

Grünenthal announced today that its U.S. subsidiary, Averitas Pharma, Inc., has completed recruitment for the Phase III clinical trial AV001. The trial investigates the efficacy, safety and ...

A wearable, app-controlled wireless device that stimulates nerves in the legs and feet may help individuals with cancer who suffer from burning and shooting pain and cramping in their lower limbs ...